You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myleran

Showing 26 - 50 of 95
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease, Hemoglobin SC Trial in Houston (Busulfan, Campath 1H, Cyclophosphamide and MESNA)

Terminated
Has Results
  • Sickle Cell Disease
  • Hemoglobin SC
  • Houston, Texas
  • +1 more
Jul 16, 2020

Acute Myeloid Leukemia, Minimal Residual Disease Negativity Trial in Seattle (procedure, drug, other)

Withdrawn
  • Acute Myeloid Leukemia
  • Minimal Residual Disease Negativity
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 27, 2021

Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +13 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 8, 2022

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Thalassemia Trial in Houston (Busulfan, Fludarabine, Campath 1H)

Terminated
Has Results
  • Thalassemia
  • Houston, Texas
    Texas Children's Hospital
Apr 30, 2020

Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)

Completed
  • Ewing Sarcoma
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 14, 2020

Myeloma Trial in Houston (Palifermin, Dexamethasone, Gemcitabine)

Completed
Has Results
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)

Completed
Has Results
  • Stem Cell Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2020

Hematologic Malignancies Trial in Chicago (procedure, drug, radiation)

Terminated
Has Results
  • Hematologic Malignancies
  • Haploidentical Transplant
  • +4 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Feb 12, 2020

Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in

Withdrawn
  • Allogeneic Stem Cell Transplant Recipient
  • +2 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2020

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
Has Results
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Myeloma Trial in Houston (drug, other, procedure)

Completed
Has Results
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 7, 2020

Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)

Completed
  • Myelodysplastic Syndrome
  • Leukemia
  • Cord Blood Infusion
  • +11 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 27, 2020

Lymphoma Trial in Houston (Gemcitabine, Busulfan, Melphalan)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 13, 2019

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
Has Results
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Acute Lymphoblastic Leukemia, Adult Trial in Mexico City (Gemcitabine, Busulfan, Cyclophosphamide)

Unknown status
  • Acute Lymphoblastic Leukemia, Adult
  • Mexico City, Distrito Federal, Mexico
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020

Triple-Negative Invasive Breast Carcinoma, Residual Tumor Trial in Mexico City (Carmustine, Cyclophosphamide, Carboplatin)

Unknown status
  • Triple-Negative Invasive Breast Carcinoma
  • Residual Tumor
  • Mexico City, Distrito Federal, Mexico
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020

Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial in Mexico City (Busulfan, Cyclophosphamide, CXCR4 Antagonist)

Unknown status
  • Acute Myeloid Leukemia
  • Acute Lymphoid Leukemia
  • Mexico City, Distrito Federal, Mexico
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020

Lymphoma Trial in Houston (Lenalidomide, Vorinostat, Gemcitabine)

Terminated
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 26, 2019

Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +46 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 10, 2021

Myelofibrosis Trial in Houston (Busulfan, Fludarabine, Thymoglobulin (ATG))

Completed
Has Results
  • Myelofibrosis
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 13, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Phoenix, Duarte (biological, drug, procedure)

Completed
Has Results
  • Multiple Myeloma and Plasma Cell Neoplasm
  • filgrastim
  • +7 more
  • Phoenix, Arizona
  • +1 more
Jun 24, 2019

Leukemia, Lymphoma, Neuroblastoma Trial in New York (Alemtuzumab, Total Body Irradiation, Melphalan)

Terminated
Has Results
  • Leukemia
  • +4 more
  • New York, New York
    Columbia Presbyterian Medical Center
Mar 4, 2019

Leukemia Trial in Houston (drug, radiation, biological)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 22, 2019

Philadelphia Negative Myeloproliferative Tumors Trial

Not yet recruiting
  • Philadelphia Negative Myeloproliferative Neoplasms
    • (no location specified)
    Jun 5, 2022